

Drug Class: Amylin Analogue, Appetite Suppressant
Composition: Cagrilintide Acetate
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial
Form: Lyophilized Powder
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Dragon Pharma Cagrilintide delivers 10 mg of pharmaceutical-grade Cagrilintide Acetate per 2 mL vial. This advanced peptide works as a long-acting amylin receptor agonist designed to suppress appetite, regulate satiety, and support consistent weight reduction without harsh stimulants or hormonal disruption.
Cagrilintide is a synthetic amylin analog that mimics the effects of the natural hormone co-secreted with insulin. It acts on the brain's appetite-regulating centers to increase fullness, reduce food cravings, and slow gastric emptying. According to clinical research published by NIH, Cagrilintide has shown significant efficacy in reducing body weight when used alone or in combination with GLP-1 receptor agonists like Semaglutide.
Cagrilintide is ideal for cutting cycles, recomp goals, or individuals seeking long-term weight management without hormonal suppression.
Administered via subcutaneous injection, a common protocol begins at 0.3 mg/week and may titrate up to 2.4 mg/week based on tolerance and weight loss response. Due to its long half-life (~7–8 days), Cagrilintide is injected only once per week. Best results are achieved when combined with a controlled diet and active lifestyle.
For synergistic results, Dragon Pharma Cagrilintide can be stacked with:
Cagrilintide is generally well tolerated. Possible side effects may include mild nausea, constipation, or reduced appetite, especially during the first 1–2 weeks. Start at the lowest dose to assess your body's response.
Dragon Pharma ensures all peptides are GMP-compliant and lab verified for purity and potency. With reliable USA shipping and unmatched product consistency, our Cagrilintide offers a trusted solution for next-level fat loss and metabolic support.
Explore more high-quality peptides in the Dragon Pharma USA performance line.
Name: Cagrilintide
Drug Class: Amylin Analogue, Appetite Suppressant
Other common names and terms: AM 833
Active Life: ~7 days
Detection Time: Several weeks
Chemical Structure: Long-acting amylin receptor agonist (non-insulin peptide)
Common Doses: 0.5 - 4.5 mg, once weekly
Blood pressure: Can cause a slight decrease
Acne: No
Water retention: No
Aromatisation: No
Liver toxicity: None reported in clinical trials
Decrease HPTA function: No
Cagrilintide is used for appetite suppression and weight loss. It mimics amylin to increase satiety, reduce food intake, and support body fat reduction.
No. Cagrilintide is an amylin analog, while Semaglutide is a GLP-1 agonist. They work on different receptors but complement each other well in fat loss protocols.
Appetite suppression can begin within the first week, with visible weight loss commonly reported after 2–4 weeks of consistent weekly dosing.
Yes. Clinical studies show that combining the two may result in superior weight loss outcomes due to their synergistic mechanisms of action.
Not typically, especially when followed by a proper maintenance plan. It may help establish long-term appetite control habits if used correctly.
Please log in to write Cagrilintide Acetate 10 mg review.
For Intramuscular Injection
Composition:
- Testosterone Propionate 42 mg
- Testosterone Phenylropionate 84 mg
- Testosterone Isocaproate 84 mg
- Testosterone Decanoate 140 mg
Mixed Dosage: 350 mg/1 mL
Unit: 10 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals
For Oral Administration
Composition: Clenbuterol Hydrochloride
Dosage: 40 mcg/tablet
Unit: 100 Tablets
Manufactured by Axiolabs
Laboratory Test: View Lab Report